Low HPV vaccine coverage among female community college students

Journal of Community Health

Volumn 37, Issue 6, 2012, Pages 1136-1144

  Marchand, Erica ^a   Glenn, Beth A ^a   Bastani, Roshan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical cancer prevention; College women; Community college; Ethnic minority women; HPV vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CLASSIFICATION; CULTURAL ANTHROPOLOGY; ETHNOLOGY; FEMALE; HUMAN; IMMUNIZATION; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; STATISTICS; STUDENT; UNITED STATES; UNIVERSITY;

ADOLESCENT; ADULT; CULTURAL DIVERSITY; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; IMMUNIZATION SCHEDULE; LOS ANGELES; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; STUDENTS; UNIVERSITIES; YOUNG ADULT;

EID: 84872262968     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-012-9572-x     Document Type: Article

References (23)

1. Romanowski, B., de Borba, P. C., Naud, P. S., et al. (2009). Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: Analysis of a randomized placebo-controlled trial up to 6.4 years. Lancet, 374, 1975-1985.
2. Villa, L. L., Costa, R. L. R., Petta, C. A., et al. (2006). High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. British Journal of Cancer, 95, 1459-1466.
3. CDC. (2011). Recommended adult immunization schedule - United States, 2011. MMWR, 60(4), 1-4.
4. CDC. (2012). Adult vaccination coverage - United States, 2010. MMWR, 61(4), 66-72.
5. Chao, C., Velicer, C., Slezak, J., & Jacobsen, S. (2010). Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. American Journal of Epidemiology, 171, 357-367.
6. Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine, 29(3), 528-534.
7. Licht, A. S., Murphy, J. M., Hyland, A. J., Fix, B. V., Hawk, L. W., & Mahoney, M. C. (2010). Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? Sexually Transmitted Infection, 86, 74-78.
8. Chandra, A., Mosher, W. D., Copen, C., & Sionean, C. (2011). Sexual behavior, sexual attraction, and sexual identity in the United States: Data from the 2006-2008 National Survey of Family Growth. National Health Statistics Reports, 36, 1-28.
9. Paavonen, J. (2010). At what age should we be vaccinating for human papillomavirus? Gynecologic and Obstetric Investigation, 70, 233-236.
10. Bynum, S. A., Brandt, H. M., Sharpe, P. A., Williams, M. S., & Kerr, J. C. (2011). Working to close the gap: Identifying predictors of HPV vaccine uptake among young African American women. Journal of Health Care for the Poor and Underserved, 22, 549-561.
11. Rosenthal, S. L., Weiss, T. W., Zimet, G. D., Ma, L., Good, M. B., & Vichnin, M. D. (2011). Predictors of HPV vaccine uptake among women aged 19-26: Importance of a physician's recommendation. Vaccine, 29, 890-895.
12. Roberts, M., Gerrard, M., Reimer, R., & Gibbons, F. (2010). Mother-daughter communication and human papillomavirus vaccine uptake by college students. Pediatrics, 125(5), 982-989.
13. Tiro, J. A., Tsui, J., Bauer, H. M., Yamada, E., Kobrin, S., & Breen, N. (2012). Uptake and correlates of the human papillomavirus vaccine among adolescent girls and young adult women: An analysis of the 2007 California Health Interview Survey. Journal of Women's Health, 21, 1-10.
14. Los Angeles Community College District. (2011). Research and statistics: Student characteristics. http://research.laccd.edu/student-characteristics/ index.htm.
15. Bastani, R., Glenn, B. A., Taylor, V. M., Chen, M. S., Nguyen, T. T., Stewart, S. L., et al. (2010). Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Preventive Medicine, 50, 63-67.
16. Allen, J., Othus, M., Shelton, R. C., Li, Y., Norman, N., Tom, L., et al. (2010). Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers and Prevention, 19(9), 2187-2198.
17. Bastani, R., Glenn, B., Tsui, J., Chang, C., Marchand, E., Taylor, V., et al. (2011). Understanding sub-optimal HPV vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers and Prevention, 20, 1463-1472.
18. Metzler, C. W., Noell, J., & Biglan, A. (1992). The validation of a construct of high-risk sexual behavior in heterosexual adolescents. Journal of Adolescent Research, 7(2), 233-249.
19. Safran, D. G., Kosinski, M., Tarlov, A. R., Rogers, W. H., Taira, D. A., Lieberman, N., et al. (1998). The Primary Care Assessment Survey: Tests of data quality and measurement performance. Medical Care, 36(5), 728-739.
20. Lau, M., Lin, H., & Flores, G. (2012). Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in U.S. adolescent females: 2007 National Survey of Children's Health. Vaccine, 30, 3112-3118.
21. Gee, J., Naleway, A., Shul, I., et al. (2011). Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine, 29, 8279-8284.
22. Haupt, R. M., & Sings, H. L. (2011). The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine Gardasil. Journal of Adolescent Health, 49, 467-475.
23. Stupiansky, N. W., Zimet, G. D., Cummings, T., Fortenberry, J. D., & Shew, M. (2012). Accuracy of self-reported human papillomavirus vaccine receipt among adolescent girls and their mothers. Journal of Adolescent Health, 50, 103-105.